Senesco Technologies, Inc.

Research - Bridgewater, New Jersey, United States

Senesco Technologies, Inc. Details

Senesco is running a Phase 1/2 study in multiple myeloma, diffuse large B-cell lymphoma and mantle cell lymphoma patients with a novel gene regulatory approach. The ability of eukaryotic translation initiation factor 5A (eIF5A) to modulate critical pathways involved in cancer and inflammatory diseases is being investigated.

Senesco Technologies, Inc. logo, Senesco Technologies, Inc. contact details
Employees: 4
HQ: (908) 864-4444
Location: Bridgewater, New Jersey, United States
Revenue:

Contacting Senesco Technologies, Inc.: Connect with Executives and Employees

Get in Touch with Senesco Technologies, Inc. Executives and Employees

Connecting with Senesco Technologies, Inc.'s Executives and Workforce

Accessing Contact Information for Senesco Technologies, Inc. Executives

Connecting with Senesco Technologies, Inc.: Reach Out to Their Team

Discover How to Contact Senesco Technologies, Inc. Executives and Staff

Looking to connect with Senesco Technologies, Inc. executives or employees?

Seeking to Get in Touch with Senesco Technologies, Inc. Executives or Staff?

Want to Reach Out to Senesco Technologies, Inc. Executives or Team Members?

In Search of Contact Details for Senesco Technologies, Inc. Professionals?

Connecting with Senesco Technologies, Inc.: Contacting Executives and Staff

Browse companies
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z